USD 105.0
(1.04%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.02 Billion USD | 9.21% |
2022 | 937.99 Million USD | -1.01% |
2021 | 947.58 Million USD | 6.16% |
2020 | 892.58 Million USD | 40.18% |
2019 | 636.74 Million USD | 79.17% |
2018 | 355.38 Million USD | 33.05% |
2017 | 267.11 Million USD | 15.62% |
2016 | 231.03 Million USD | 19.95% |
2015 | 192.61 Million USD | 6.53% |
2014 | 180.8 Million USD | 10.29% |
2013 | 163.93 Million USD | 9.39% |
2012 | 149.85 Million USD | -3.13% |
2011 | 154.69 Million USD | -7.33% |
2010 | 166.92 Million USD | 3.48% |
2009 | 161.31 Million USD | 18.83% |
2008 | 135.74 Million USD | 14.4% |
2007 | 118.65 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.01 Billion USD | -1.02% |
2024 Q2 | 1.11 Billion USD | 10.11% |
2024 Q3 | 1.15 Billion USD | 3.26% |
2023 Q2 | 928.38 Million USD | -0.29% |
2023 Q3 | 1.03 Billion USD | 11.56% |
2023 Q4 | 1.02 Billion USD | -1.09% |
2023 FY | 1.02 Billion USD | 9.21% |
2023 Q1 | 931.08 Million USD | -0.74% |
2022 Q3 | 945.93 Million USD | -1.93% |
2022 Q2 | 964.52 Million USD | -2.3% |
2022 FY | 937.99 Million USD | -1.01% |
2022 Q1 | 987.21 Million USD | 4.18% |
2022 Q4 | 937.99 Million USD | -0.84% |
2021 Q4 | 947.58 Million USD | 2.45% |
2021 Q3 | 924.91 Million USD | 4.02% |
2021 Q2 | 889.16 Million USD | 1.32% |
2021 Q1 | 877.57 Million USD | -1.68% |
2021 FY | 947.58 Million USD | 6.16% |
2020 Q4 | 892.58 Million USD | 28.35% |
2020 FY | 892.58 Million USD | 40.18% |
2020 Q1 | 644.81 Million USD | 1.27% |
2020 Q3 | 695.43 Million USD | 5.22% |
2020 Q2 | 660.92 Million USD | 2.5% |
2019 Q3 | 619.11 Million USD | 51.49% |
2019 Q2 | 408.68 Million USD | 7.85% |
2019 FY | 636.74 Million USD | 79.17% |
2019 Q1 | 378.92 Million USD | 6.62% |
2019 Q4 | 636.74 Million USD | 2.85% |
2018 Q4 | 355.38 Million USD | -17.5% |
2018 Q2 | 343.42 Million USD | 25.86% |
2018 Q1 | 272.85 Million USD | 2.15% |
2018 Q3 | 430.77 Million USD | 25.44% |
2018 FY | 355.38 Million USD | 33.05% |
2017 Q3 | 267.9 Million USD | 4.57% |
2017 FY | 267.11 Million USD | 15.62% |
2017 Q4 | 267.11 Million USD | -0.3% |
2017 Q2 | 256.19 Million USD | 7.35% |
2017 Q1 | 238.66 Million USD | 3.3% |
2016 FY | 231.03 Million USD | 19.95% |
2016 Q4 | 231.03 Million USD | 0.26% |
2016 Q2 | 242.9 Million USD | 5.97% |
2016 Q1 | 229.21 Million USD | 19.01% |
2016 Q3 | 230.44 Million USD | -5.13% |
2015 Q4 | 192.61 Million USD | -1.24% |
2015 FY | 192.61 Million USD | 6.53% |
2015 Q1 | 183.29 Million USD | 1.38% |
2015 Q3 | 195.02 Million USD | 3.73% |
2015 Q2 | 188.01 Million USD | 2.58% |
2014 Q1 | 162.54 Million USD | -0.85% |
2014 Q4 | 180.8 Million USD | 3.11% |
2014 Q2 | 165.13 Million USD | 1.6% |
2014 FY | 180.8 Million USD | 10.29% |
2014 Q3 | 175.34 Million USD | 6.18% |
2013 Q4 | 163.93 Million USD | 4.61% |
2013 Q3 | 156.71 Million USD | 1.01% |
2013 Q1 | 151.35 Million USD | 1.0% |
2013 Q2 | 155.15 Million USD | 2.51% |
2013 FY | 163.93 Million USD | 9.39% |
2012 FY | 149.85 Million USD | -3.13% |
2012 Q4 | 149.85 Million USD | -1.86% |
2012 Q3 | 152.7 Million USD | 1.46% |
2012 Q2 | 150.51 Million USD | -2.51% |
2012 Q1 | 154.38 Million USD | -0.2% |
2011 Q2 | 170.05 Million USD | 6.59% |
2011 Q3 | 156.34 Million USD | -8.06% |
2011 FY | 154.69 Million USD | -7.33% |
2011 Q4 | 154.69 Million USD | -1.05% |
2011 Q1 | 159.53 Million USD | -4.42% |
2010 Q1 | 166.08 Million USD | 2.96% |
2010 Q2 | 167.99 Million USD | 1.15% |
2010 FY | 166.92 Million USD | 3.48% |
2010 Q4 | 166.92 Million USD | -3.9% |
2010 Q3 | 173.69 Million USD | 3.39% |
2009 Q3 | 144.83 Million USD | -0.75% |
2009 FY | 161.31 Million USD | 18.83% |
2009 Q2 | 145.92 Million USD | 0.0% |
2009 Q4 | 161.31 Million USD | 11.38% |
2008 FY | 135.74 Million USD | 14.4% |
2008 Q4 | 135.74 Million USD | 0.0% |
2007 FY | 118.65 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 5.35 Billion USD | 80.883% |
AirSculpt Technologies, Inc. | 213.55 Million USD | -379.708% |
Amedisys, Inc. | 2.06 Billion USD | 50.275% |
Astrana Health, Inc. | 933.36 Million USD | -9.757% |
Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 37.427% |
IMAC Holdings, Inc. | 1.14 Million USD | -89438.413% |
biote Corp. | 155.29 Million USD | -559.665% |
Cryo-Cell International, Inc. | 61.22 Million USD | -1573.331% |
Cross Country Healthcare, Inc. | 679.31 Million USD | -50.802% |
COMPASS Pathways plc | 275.98 Million USD | -271.186% |
DocGo Inc. | 490.45 Million USD | -108.874% |
The Ensign Group, Inc. | 4.17 Billion USD | 75.478% |
Healthcare Services Group, Inc. | 803.18 Million USD | -27.546% |
InnovAge Holding Corp. | 547.66 Million USD | -87.055% |
The Joint Corp. | 87.15 Million USD | -1075.463% |
LifeStance Health Group, Inc. | 2.23 Billion USD | 54.128% |
Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -12784.865% |
ModivCare Inc. | 1.76 Billion USD | 42.034% |
NewGenIvf Group Limited | 1.64 Million USD | -62082.147% |
Option Care Health, Inc. | 3.32 Billion USD | 69.221% |
P3 Health Partners Inc. | 860.96 Million USD | -18.986% |
P3 Health Partners Inc. | 860.96 Million USD | -18.986% |
The Pennant Group, Inc. | 539.69 Million USD | -89.817% |
Surgery Partners, Inc. | 7.01 Billion USD | 85.405% |
Syra Health Corp. Class A Common Stock | 4.92 Million USD | -20707.782% |
Talkspace, Inc. | 142.22 Million USD | -620.306% |
Talkspace, Inc. | 142.22 Million USD | -620.306% |
The Oncology Institute, Inc. | 219.41 Million USD | -366.883% |
The Oncology Institute, Inc. | 219.41 Million USD | -366.883% |